UB Paderborn / Katalog / Suche / in CDI

Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial

Journal of clinical oncology, 2023-08, Vol.41 (24), p.JCO2202392-4013

2023

Volltextzugriff (PDF)

Barriers to Implementation of Breast Cancer Risk Assessment: The Health Care Team Perspective

Journal of the American College of Radiology, 2023-03, Vol.20 (3), p.342-351

2023

Volltextzugriff (PDF)

Black Women’s Perspectives on Breast Cancer Risk Assessment

Journal of the American College of Radiology, 2023-03, Vol.20 (3), p.314-323

2023

Volltextzugriff (PDF)

Next Top Model: An Overview of Breast Cancer Risk Assessment Models

Applied radiology (1976), 2024-01, Vol.53 (1), p.8-15

2024

Volltextzugriff (PDF)

Reimaging metastatic breast cancer care delivery: A patient-partnered qualitative investigation

Journal of clinical oncology, 2022-10, Vol.40 (28_suppl), p.259-259

2022

Volltextzugriff (PDF)

Integrated clinical, pathologic, and genetic data in a racially diverse hereditary breast cancer cohort

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.10553-10553

2023

Volltextzugriff (PDF)

Impact of race on BluePrint genomic subtyping in HER2+ breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.564-564

2023

Volltextzugriff (PDF)

Whole transcriptomic analysis of HR+ breast cancer in Black women classified as basal-type by BluePrint

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.517-517

2022

Volltextzugriff (PDF)

Circulating tumor cells (CTCs) dynamics after CDK4/6i for hormone-receptor positive (HR+) metastatic breast cancer (MBC): A biomarker analysis of the PACE randomized phase II study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1059-1059

2023

Volltextzugriff (PDF)

Neratinib plus fulvestrant plus trastzuzumab (N+F+T) for hormone receptor-positive (HR+), HER2-negative, HER2 -mutant metastatic breast cancer (MBC): Outcomes and biomarker analysis from the SUMMIT trial

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1028-1028

2022

Volltextzugriff (PDF)

Barriers to Implementation of Breast Cancer Risk Assessment: The Healthcare Team Perspective

Journal of the American College of Radiology, 2023-03, Vol.20 (3), p.342-351

2023

Volltextzugriff (PDF)

Update on multi‐gene panel testing and communication of genetic test results

The breast journal, 2020-08, Vol.26 (8), p.1513-1519

2020

Volltextzugriff (PDF)

Osm1 facilitates the transfer of electrons from Erv1 to fumarate in the redox-regulated import pathway in the mitochondrial intermembrane space

Molecular biology of the cell, 2017-10, Vol.28 (21), p.2773-2785

2017

Volltextzugriff (PDF)

The primacy of vital signs – Acute care nurses’ and midwives’ use of physical assessment skills: A cross sectional study

International journal of nursing studies, 2015-05, Vol.52 (5), p.951-962

2015

Volltextzugriff (PDF)

Disparities in Genetic Testing and Care Among Black Women with Hereditary Breast Cancer

Current breast cancer reports, 2020-09, Vol.12 (3), p.125-131

2020

Volltextzugriff (PDF)

Human hepatic stem cells from fetal and postnatal donors

The Journal of experimental medicine, 2007-08, Vol.204 (8), p.1973-1987

2007

Volltextzugriff (PDF)

Does Pandemic Crisis Mean Education Crisis? The Chicago Academic Plastic Surgery Collaborative Response to COVID-19

Plastic and reconstructive surgery (1963), 2021-06, Vol.147 (6), p.1469

2021

Volltextzugriff (PDF)

Elements contributing to meaningful participation for children and youth with disabilities: a scoping review

Disability and rehabilitation, 2017-08, Vol.39 (17), p.1771-1784

2017

Volltextzugriff (PDF)

Using Social Signals to Predict Shoplifting: A Transparent Approach to a Sensitive Activity Analysis Problem

Sensors (Basel, Switzerland), 2021-10, Vol.21 (20), p.6812

2021

Volltextzugriff (PDF)

"Our Mothers Have Handed That to Us. Her Mother Has Handed That to Her": Urban Aboriginal and Torres Strait Islander Yarning about Community Wellbeing, Healthy Pregnancies, and the Prevention of Fetal Alcohol Spectrum Disorder

International journal of environmental research and public health, 2023-04, Vol.20 (9), p.5614

2023

Volltextzugriff (PDF)

An overview of genetic services delivery for hereditary breast cancer

Breast cancer research and treatment, 2022-02, Vol.191 (3), p.491-500

2022

Volltextzugriff (PDF)

The effectiveness and cost effectiveness of a hospital avoidance program in a residential aged care facility: a prospective cohort study and modelled decision analysis

BMC geriatrics, 2020-12, Vol.20 (1), p.527-527, Article 527

2020

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial

A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

Barriers to Implementation of Breast Cancer Risk Assessment: The Health Care Team Perspective

Black Women’s Perspectives on Breast Cancer Risk Assessment

Next Top Model: An Overview of Breast Cancer Risk Assessment Models

Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis

Reimaging metastatic breast cancer care delivery: A patient-partnered qualitative investigation

Integrated clinical, pathologic, and genetic data in a racially diverse hereditary breast cancer cohort

Impact of race on BluePrint genomic subtyping in HER2+ breast cancer

Whole transcriptomic analysis of HR+ breast cancer in Black women classified as basal-type by BluePrint

Circulating tumor cells (CTCs) dynamics after CDK4/6i for hormone-receptor positive (HR+) metastatic breast cancer (MBC): A biomarker analysis of the PACE randomized phase II study

Neratinib plus fulvestrant plus trastzuzumab (N+F+T) for hormone receptor-positive (HR+), HER2-negative, HER2 -mutant metastatic breast cancer (MBC): Outcomes and biomarker analysis from the SUMMIT trial

Barriers to Implementation of Breast Cancer Risk Assessment: The Healthcare Team Perspective

Update on multi‐gene panel testing and communication of genetic test results

Osm1 facilitates the transfer of electrons from Erv1 to fumarate in the redox-regulated import pathway in the mitochondrial intermembrane space

The primacy of vital signs – Acute care nurses’ and midwives’ use of physical assessment skills: A cross sectional study

Disparities in Genetic Testing and Care Among Black Women with Hereditary Breast Cancer

Human hepatic stem cells from fetal and postnatal donors

Does Pandemic Crisis Mean Education Crisis? The Chicago Academic Plastic Surgery Collaborative Response to COVID-19

Elements contributing to meaningful participation for children and youth with disabilities: a scoping review

Using Social Signals to Predict Shoplifting: A Transparent Approach to a Sensitive Activity Analysis Problem

"Our Mothers Have Handed That to Us. Her Mother Has Handed That to Her": Urban Aboriginal and Torres Strait Islander Yarning about Community Wellbeing, Healthy Pregnancies, and the Prevention of Fetal Alcohol Spectrum Disorder

An overview of genetic services delivery for hereditary breast cancer

The effectiveness and cost effectiveness of a hospital avoidance program in a residential aged care facility: a prospective cohort study and modelled decision analysis

Suchergebnisse filtern